Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

British King Charles (left) leaving the London Clinic following treatment earlier this year. Alamy Stock Photo

Britain's King Charles' cancer treatment ‘to continue into next year’

Sources told Sky News that his treatment is moving in a positive direction.

BRITAIN’S KING CHARLES’ cancer treatment is expected to continue into 2025, almost a year after it was discovered while he was treated in hospital for an enlarged prostate.

Buckingham Palace sources told Sky News that “his treatment has been moving in a positive direction and as a managed condition the treatment cycle will continue into next year”.

Further details of his condition have not been disclosed as spokespeople have asked for privacy when announcing the diagnosis in February, only confirming it is a “form of cancer”.

Charles was diagnosed while he was being treated for his benign prostate condition. He cancelled all face-to-face public duties but returned in April.

He has since travelled to France for D-Day commemorations, hosted an incoming state visit for the Emperor of Japan, and undertaken a hectic tour to Australia and Samoa with Camilla, despite still undergoing outpatient cancer treatment.

Close
54 Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel

     
    JournalTv
    News in 60 seconds